Back to top

DuPont, Kateeva Partner to Advance OLED Inkjet Printing

Read MoreHide Full Article

DuPont (DD - Free Report) and inkjet equipment maker Kateeva have collaborated to develop optimized inks, equipment, and processes to further advance inkjet printing technology for Organic Light Emitting Diode (OLED) display devices.

The companies will utilize each other’s expertise, including DuPont’s technical leadership in solution materials for printed OLED devices and Kateeva's exclusive YIELDjet inkjet printing platform, to benefit OLED manufacturers. The aim is to offer the manufactures a mass-production equipment solution with lower cost-of-ownership advantages than the vacuum evaporation technologies currently used to pattern red, green and blue (RGB) OLED pixels.

The YIELDjet platform enables the manufacturers to maximize OLED device lifetime and quality. It also offers ultra-low particle performance, consistent process reliability, and high uptime.

The partnership between the two companies is non-exclusive and aims at increasing the viability and the manufacturing-ready options for the manufacturers. The objective of the alliance is to provide a simple and very effective process for manufacturing OLED TV displays using inkjet technology. The companies also expect to provide cross-referenced data for DuPont materials with Kateeva printing equipment and look forward to achieving low cost mass production of OLED TV.

Kateeva makes breakthrough production equipment for manufacturers of advanced electronics technologies while DuPont have been providing OLED materials for evaporative and solution-based echnologies for more than 15 years.

DuPont is a Zacks Rank #3 (Hold).

Better-ranked stocks in the chemical space include LyondellBasell Industries N.V. (LYB - Free Report) , Celanese Corp. (CE - Free Report) and Trecora Resources (TREC - Free Report) , all sporting a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>



More from Zacks Analyst Blog

You May Like